𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth

✍ Scribed by Chuxia Deng; Anthony Wynshaw-Boris; Fen Zhou; Ann Kuo; Philip Leder

Book ID
117267962
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
919 KB
Volume
84
Category
Article
ISSN
0092-8674

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Glycosylation of fibroblast growth facto
Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19–mediated down-regulation of cytochrome P450 7A1
✍ Vassilis Triantis; Eirikur Saeland; Nora Bijl; Ronald P. Oude-Elferink; Peter L. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 684 KB

De novo bile acid synthesis in the liver needs to be tightly regulated in order to maintain optimal bile flow and prevent cholestasis. In the liver, fibroblast growth factor 19 (FGF19) regulates bile acid synthesis by down-regulating messenger RNA levels of cytochrome P450 7A1 (CYP7A1). FGF19 acts t

Basic fibroblast growth factor: A potent
Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growth
✍ J. L. Gross; Dr. R. S. Morrison; K. Eidsvoog; W. F. Herblin; P. L. Kornblith; D. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 753 KB

Basic fibroblast growth factor (bFGF) is a potent mitogen and angiogenic factor. bFGF is expressed by a variety of solid human tumors and has been implicated as an autocrine regulator of tumor growth. Different solid tumor lines including glioma, colon carcinoma and melanoma were examined for intrac

Modulation of the epidermal growth facto
Modulation of the epidermal growth factor receptor by basic fibroblast growth factor
✍ Pamela A. Maher πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 883 KB

Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi